- Home
- LEGH vs RXST Comparison
LEGH vs RXST Comparison
Compare LEGH & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGH
- RXST
- Stock Information
- Founded
- LEGH 2005
- RXST 1997
- Country
- LEGH United States
- RXST United States
- Employees
- LEGH N/A
- RXST N/A
- Industry
- LEGH Homebuilding
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LEGH Consumer Discretionary
- RXST Health Care
- Exchange
- LEGH Nasdaq
- RXST Nasdaq
- Market Cap
- LEGH 588.8M
- RXST 553.1M
- IPO Year
- LEGH 2018
- RXST 2021
- Fundamental
- Price
- LEGH $22.75
- RXST $7.97
- Analyst Decision
- LEGH Strong Buy
- RXST Hold
- Analyst Count
- LEGH 2
- RXST 12
- Target Price
- LEGH $29.00
- RXST $18.45
- AVG Volume (30 Days)
- LEGH 79.7K
- RXST 2.2M
- Earning Date
- LEGH 08-07-2025
- RXST 08-07-2025
- Dividend Yield
- LEGH N/A
- RXST N/A
- EPS Growth
- LEGH 8.04
- RXST N/A
- EPS
- LEGH 2.29
- RXST N/A
- Revenue
- LEGH $176,618,000.00
- RXST $148,310,000.00
- Revenue This Year
- LEGH N/A
- RXST $17.41
- Revenue Next Year
- LEGH $7.69
- RXST $12.44
- P/E Ratio
- LEGH $9.89
- RXST N/A
- Revenue Growth
- LEGH N/A
- RXST 46.70
- 52 Week Low
- LEGH $21.58
- RXST $6.32
- 52 Week High
- LEGH $29.31
- RXST $58.23
- Technical
- Relative Strength Index (RSI)
- LEGH 49.32
- RXST 29.51
- Support Level
- LEGH $22.32
- RXST $7.24
- Resistance Level
- LEGH $23.32
- RXST $8.10
- Average True Range (ATR)
- LEGH 0.60
- RXST 0.58
- MACD
- LEGH -0.05
- RXST 0.07
- Stochastic Oscillator
- LEGH 39.33
- RXST 24.37
About LEGH Legacy Housing Corporation (TX)
Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.